- Home
- ABEO vs GLO Comparison
ABEO vs GLO Comparison
Compare ABEO & GLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- GLO
- Stock Information
- Founded
- ABEO 1974
- GLO 2006
- Country
- ABEO United States
- GLO United States
- Employees
- ABEO N/A
- GLO N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- GLO Finance/Investors Services
- Sector
- ABEO Health Care
- GLO Finance
- Exchange
- ABEO Nasdaq
- GLO Nasdaq
- Market Cap
- ABEO 289.2M
- GLO 242.5M
- IPO Year
- ABEO 1980
- GLO N/A
- Fundamental
- Price
- ABEO $5.26
- GLO $5.73
- Analyst Decision
- ABEO Strong Buy
- GLO
- Analyst Count
- ABEO 6
- GLO 0
- Target Price
- ABEO $18.17
- GLO N/A
- AVG Volume (30 Days)
- ABEO 1.1M
- GLO 170.5K
- Earning Date
- ABEO 11-13-2025
- GLO 01-01-0001
- Dividend Yield
- ABEO N/A
- GLO 11.38%
- EPS Growth
- ABEO N/A
- GLO N/A
- EPS
- ABEO 0.99
- GLO N/A
- Revenue
- ABEO $400,000.00
- GLO N/A
- Revenue This Year
- ABEO N/A
- GLO N/A
- Revenue Next Year
- ABEO $324.71
- GLO N/A
- P/E Ratio
- ABEO $5.31
- GLO N/A
- Revenue Growth
- ABEO N/A
- GLO N/A
- 52 Week Low
- ABEO $3.93
- GLO $4.08
- 52 Week High
- ABEO $7.54
- GLO $5.18
- Technical
- Relative Strength Index (RSI)
- ABEO 31.86
- GLO 60.20
- Support Level
- ABEO $5.19
- GLO $5.66
- Resistance Level
- ABEO $5.49
- GLO $5.77
- Average True Range (ATR)
- ABEO 0.19
- GLO 0.05
- MACD
- ABEO 0.01
- GLO -0.00
- Stochastic Oscillator
- ABEO 12.84
- GLO 62.76
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About GLO Clough Global Opportunities Fund
Clough Global Opportunities Fund is a closed-end management investment company based in the United States. Its investment objective is to provide a high level of total return by investing in equity securities of companies of any market capitalization and equity-related securities, including equity swaps and call options, as well as fixed-income securities, including both corporate and sovereign debt, in both U.S. and non-U.S. markets.